Britain covid-19 patient Merck Britain

U.K. approves Merck antiviral pill to treat COVID-19

Reading now: 541
globalnews.ca

COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms, citing clinical data.

Experimental pill fights COVID-19, drug-maker Merck claims This is the first oral antiviral treatment for COVID-19 to get approved, with the green light coming ahead of potential U.S.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA